Lindbrook Capital’s Pulse Biosciences PLSE Stock Holding History

Lindbrook Capital’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-156	Closed	-$1.36K	–	2823
2024 Q1	$1.36K	Buy	+156	New	+$1.43K	﹤0.01%	2357

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lindbrook Capital's PLSE Position: Q2 2024 in Review

Lindbrook Capital sold out of Pulse Biosciences (PLSE) in Q2 2024, closing a stake of 156 shares — an estimated $1.36K sold.

Lindbrook Capital first reported a position in PLSE in Q1 2024 and held it in 1 quarter. The position peaked at $1.36K in Q1 2024. 57 funds tracked by Wall St. Rank hold PLSE as of Q2 2024.

Lindbrook Capital reported no remaining Pulse Biosciences position as of Q2 2024 after selling out during the quarter.
Lindbrook Capital sold 156 Pulse Biosciences shares in Q2 2024, an estimated $1.36K.
Lindbrook Capital first reported a position in Pulse Biosciences in Q1 2024 and held it in 1 quarter.
Lindbrook Capital's Pulse Biosciences position peaked at $1.36K in Q1 2024.
57 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2024.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.